Physicochemical and structural characterization of quercetin-β- cyclodextrin complexes

Journal of Pharmaceutical Sciences

Volumn 94, Issue 5, 2005, Pages 1079-1089

  Zheng, Ying ^a   Haworth, Ian S ^b   Zuo, Zhong ^a   Chow, Moses S S ^a   Chow, Albert H L ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Complexation; Molecular modeling; NMR spectroscopy; Quercetin; Solubility; Stability; cyclodextrins

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; BETA CYCLODEXTRIN SULFOBUTYL ETHER; FISETIN; PHLOROGLUCINOL; PHLOROGLUCINOLCARBOXYLIC ACID; PROTOCATECHUIC ACID; QUERCETIN;

ALKALINITY; ARTICLE; COMPLEX FORMATION; DRUG ABSORPTION; DRUG SOLUBILITY; HYDROPHOBICITY; INTESTINE FLUID; MOLECULAR DYNAMICS; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; SOLVATION;

EID: 20344390806     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20325     Document Type: Article

References (25)

1. Formica JV, Regelson W. 1995. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33:1061-1080.
2. Makris DP, Rossiter JT. 2000. Quercetin and rutin (quercetin 3-O-rhamnosylglucoside) thermal degradation in aqueous media under alkaline conditions. In: Buttriss J, Saltmarsh M, editors. Functional foods II: Claims and evidence. Cambridge, UK: Royal Society of Chemistry, pp 216-238.
3. Chen X, Zuo Z, Chow AHL, Chow MSS. 2001. Low bioavailability of quercetin in rats: Contributions by the gut and liver. AAPS PharmSci 3(S1). Abstract R5177. Available from: http://www. aapspharmsci.org/.
4. Manach C, Morand C, Crespy V, Demigné C, Taxier O, Régérat F, Rémésy C. 1998. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426:331-336.
5. Gugler R, Leschik M, Dengler HJ. 1975. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 9:229-234.
6. Szejtli J. 1994. Medicinal applications of cyclodextrins. Med Res Rev 14:353-386.
7. Stella VJ, Rajewski RA. 1997. Cyclodextrins: Their future in drug formulation and delivery. Pharm Res 14:556-567.
8. Zheng Y, Ko WH, Chow MSS, Zuo Z, Chow AHL. 2001. Transport mechanisms of quercetin and its glycosides across human intestinal Caco-2 cell monolayers. Abstracts, EUFEPS world conference on drug absorption and drug delivery benefiting from the new biology and informatics. Copenhagen, Denmark, pp 72-73.
9. Chen X, Zuo Z, Chow AHL, Yin OQP, Chow MSS. 2001. The bioavailability of quercetin in the solution of hydroxypropyl-beta-cyclodextrin in rats. Abstracts, EUFEPS world conference on drug absorption and drug delivery benefiting from the new biology and informatics. Copenhagen, Denmark, pp 84-85.
10. Higuchi T, Connors KA. 1965. Phase-solubility techniques. Adv Anal Chem Instr 4:117-212.
11. Sauerwald N, Schwenk M, Polster J, Bengsch E. 1998. Spectrometric pK determination of dephnetin, chlorogenic acid, and quercetin. Z. Naturforsch (B) 53:315-321.
12. Djedaïni F, Lin SZ, Perly B, Wouessidjewe D. 1990. High-field nuclear magnetic resonance techniques for the investigation of a β-cyclodextrin: Indomethacin inclusion complex. Pharm Res 79:643-646.
13. Pearlman DA, Case DA, Caldwell JC, Seibel GL, Singh UC, Weiner P, Kollman PA. 1991. AMBER, version 4.0. San Francisco: University of California.
14. Homans SW. 1990. A molecular mechanical force field for the conformational analysis of oligosaccharides: Comparison of the theoretical and crystal structures of Manα1-3Manβ1-4GlcNAc. Biochemistry 29:9110-9118.
15. Zuo Z, Kwon G, Stevenson B, Diakur J, Wiebe LI. 2000. Flutamide-hydroxypropyl-β-cyclodextrin complex: Formulation, physical characterization, and absorption studies using the Caco-2 in vitro model. J Pharm Pharmaceut Sci 3:220-227.
16. Dollo G, Corre PL, Chollet M, Chevanne F, Bertault M, Burgot J-L, Verge RL. 1999. Improvement in solubility and dissolution rate of 1,2-dithiole-3- thiones upon complexation with β-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives. J Pharm Sci 88:889-895.
17. 7M-β-CD to HP-β-CD. Pharm Res 18:667-673.
18. Shpigun OA, Ananieva IA, Budanova N Yu, Shapovalova EN. 2003. Use of cyclodextrins for separation of enantiomers. Russ Chem Rev 72: 1035-1054.
19. Murota K, Shimizu S, Chujo H, Moon JH, Terao J. 2000. Efficiency of absorption in metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Arch Biochem Biophys 384:391-397.
20. Pralhad T, Rajendrakumar K. 2004. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. J Pharm Biomed Anal 34:333-339.
21. Loftsson T, Brewster ME. 1996. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85:1017-1025.
22. 1H nuclear magnetic resonance spectroscopy of flavonoids and their glycosides in hexadeuterodimethylsulfoxide. In: Harborne JB. editor. The flavonoids, advances in research since 1986. London: Chapman & Hall, pp 441-473.
23. Kriz Z, Koca J, Imberty A, Chariot A, Auzely-Velty R. 2003. Investigation of the complexation of (+)-catechin by β-cyclodextrin by a combination of NMR, microcalorimetry and molecular modeling techniques. Org Biomol Chem 1:2590-2595.
24. Matsui T, Iwasaki H, Matsumoto K, Osajima Y. 1994. NMR studies of cyclodextrin inclusion complex with ethyl hexanoate in ethanol solution. Biosci Biotech Biochem 58:1102-1106.
25. Junquera E, Ruiz D, Aicart E. 1999. Role of hydrophobic effect on the noncovalent interactions between salicylic acid and a series of β-cyclodextrins. J Colloid Interface Sci 216:154-160.